News for Healthier Living

GLP-1 Shows Promise for Patients with Advanced Fatty Liver Disease

GLP-1 semaglutide shows improved liver scarring in advanced MASH, early cirrhosis, offering a potential new treatment option in a large global trial study.

July 16, 2026


July 20 2026

July 17 2026

July 16 2026

July 15 2026

July 14 2026

July 13 2026

July 12 2026

July 10 2026

July 9 2026

July 8 2026

July 7 2026